{
    "clinical_study": {
        "@rank": "21512", 
        "acronym": "buffering SLN", 
        "arm_group": [
            {
                "arm_group_label": "pH altered first", 
                "arm_group_type": "Active Comparator", 
                "description": "The first injection administered will be the pH altered solution.  The second injection will be the standard of care solution (opposite order).  The remaining injections will be randomly assigned as either standard of care or pH altered."
            }, 
            {
                "arm_group_label": "Standard of Care first", 
                "arm_group_type": "Active Comparator", 
                "description": "The first injection administered will be the standard of care solution (SOC).  The second injection will be the pH altered solution.  The remaining injections will be randomly assigned as either standard of care or pH altered."
            }
        ], 
        "brief_summary": {
            "textblock": "Pain during nuclear medicine breast lymphnode detection procedures has been reported as high\n      as 8.8/10.  Using Sodium Bicarbonate to alkalinize the radio-pharmaceutical injection, pain\n      can safely be reduced from 6.6/10 to 4.7/10, during breast lymph node detection procedures.\n\n      In sites other then the breast, using Bicarbonate to make the injection's pH closer to\n      natural, attempts to lower the pain levels will be performed.\n\n      Hypothesis: The perceived pain level during non breast sentinel lymph node techniques can be\n      reduced by raising the pH of the injectate (Tc-99m SC) to near the physiologic level of pH\n      7.40."
        }, 
        "brief_title": "Does Alkalinization Reduce Perceived Pain Levels During Sentinel Lymph Node Imaging?", 
        "condition": "Pain", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients presenting for SLN imaging for melanoma or who have had an excisional biopsy\n             for melanoma of the thorax and appendicular structures;\n\n          -  Patients scheduled to receive two or more injections of Tc-99m SC for the purpose of\n             clinical management of melanoma or who have had an excisional biopsy for melanoma of\n             the thorax and appendicular structures.\n\n        Exclusion Criteria:\n\n          -  Patients presenting for SLN imaging of lesions involving the breast, ear, nose, and\n             genitourinary regions;\n\n          -  Patients scheduled to receive only a single injection of Tc-99m SC;\n\n          -  Pregnant or breast feeding women."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01660412", 
            "org_study_id": "31337"
        }, 
        "intervention": [
            {
                "arm_group_label": "Standard of Care first", 
                "description": "For the second injection, and randomly after that, Sodium Bicarbonate will be compounded with Tc-99m SC, to raise the pH up to ~7.40.", 
                "intervention_name": "Standard of Care First", 
                "intervention_type": "Drug", 
                "other_name": "Sodium Bicarbonate second"
            }, 
            {
                "arm_group_label": "pH altered first", 
                "description": "For the first injection, Sodium Bicarbonate will be compounded with Tc-99m SC, to raise the pH up to ~7.40.  For the second injection, the standard of care will be given, and randomly after that either standard of care, or pH altered will be given.", 
                "intervention_name": "ph Altered first", 
                "intervention_type": "Drug", 
                "other_name": "Sodium Bicarbonate first"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Pain", 
            "Alkalinization", 
            "Technetium 99m Sulfur Colloid", 
            "sentinel lymphoscintigraphy?"
        ], 
        "lastchanged_date": "January 27, 2014", 
        "location": {
            "contact": {
                "email": "jantambi@uams.edu", 
                "last_name": "Ntambi A James, MD", 
                "phone": "501-686-6901"
            }, 
            "facility": {
                "address": {
                    "city": "Little Rock", 
                    "country": "United States", 
                    "state": "Arkansas", 
                    "zip": "72205"
                }, 
                "name": "UAMS"
            }, 
            "investigator": {
                "last_name": "Ntambi A James, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Does Alkalinization of Technetium-99m Sulfur Colloid Reduce Perceived Pain Levels During Non-breast Sentinel Lymphoscintigraphy?", 
        "overall_contact": {
            "email": "jantambi@uams.edu", 
            "last_name": "James A Ntambi, MD", 
            "phone": "5016866901"
        }, 
        "overall_contact_backup": {
            "email": "nlhilliard@uams.edu", 
            "last_name": "Nicki Hilliard, Pharm D", 
            "phone": "501 686 6398"
        }, 
        "overall_official": {
            "affiliation": "UAMS", 
            "last_name": "James A Ntambi, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Immediately after receiving an injection, subjects will rate their perceived pain level, using a validated measure.", 
            "measure": "Perceived Pain level", 
            "safety_issue": "No", 
            "time_frame": "immediately after administration (<1 min)"
        }, 
        "reference": [
            {
                "PMID": "18676334", 
                "citation": "Fetzer S, Holmes S. Relieving the pain of sentinel lymph node biopsy tracer injection. Clin J Oncol Nurs. 2008 Aug;12(4):668-70."
            }, 
            {
                "PMID": "19664956", 
                "citation": "Stojadinovic A, Peoples GE, Jurgens JS, Howard RS, Schuyler B, Kwon KH, Henry LR, Shriver CD, Buckenmaier CC. Standard versus pH-adjusted and lidocaine supplemented radiocolloid for patients undergoing sentinel-lymph-node mapping and biopsy for early breast cancer (PASSION-P trial): a double-blind, randomised controlled trial. Lancet Oncol. 2009 Sep;10(9):849-54. Epub 2009 Aug 5."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01660412"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Arkansas", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Howard J Barnhard, Resident Research Endowment.", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "UAMS DEPT of Radiology.", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Arkansas", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}